Rating History for Faeth Therapeutics (FTH) by Lucid Capital Markets

More Stocks Rated by Lucid Capital Markets | Latest Ratings for FTH
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/14/2026 Dev Prasad New Coverage Buy
(N/A)		 59.00
(N/A)		 37.44
(28.00)		 -25.21% Details